Moreover, 23 drugs targeting HLA-DMA and 8 drugs targeting PRKCG were identified through the DGIdb website.<h4>Conclusion</h4>We identified three predictive biomarkers for AD associated with clock genes, thus providing promising therapeutic targets for AD. Here, PRKCG is linked to Alzheimer disease.